Pentyl nitrite |
|
| Other names | n-Pentyl nitrate; n-Amyl nitrite; Nitramyl |
|---|
|
| CAS Number | |
|---|
| PubChem CID | |
|---|
| ChemSpider | |
|---|
| UNII | |
|---|
| ChEMBL | |
|---|
| CompTox Dashboard (EPA) | |
|---|
| ECHA InfoCard | 100.006.667 |
|---|
|
| Formula | C5H11NO2 |
|---|
| Molar mass | 117.148 g·mol−1 |
|---|
| 3D model (JSmol) | |
|---|
| Boiling point | 104 °C (219 °F) [1] |
|---|
|
InChI=1S/C5H11NO2/c1-2-3-4-5-8-6-7/h2-5H2,1H3 Key:CSDTZUBPSYWZDX-UHFFFAOYSA-N
|
Pentyl nitrite is a chemical compound with the molecular formula, classified as an alkyl nitrite, used as an antihypertensive medicine.[2] It is also used to treat cyanide poisoning.[2]
It is one of the active ingredients for a recreational drug known as poppers.
References
|
|---|
| Forms | |
|---|
| Targets | |
|---|
NO donors (prodrugs) |
- NONOates (diazeniumdiolates): Diethylamine/NO (DEA/NO)
- Diethylenetriamine/NO (DETA/NO)
- GLO/NO
- JS-K
- Methylamine hexamethylene methylamine/NO (MAHMA/NO)
- PROLI/NO
- Spermine/NO (SPER/NO)
- V-PYRRO/NO
- Unsorted: Cimlanod
- FK-409
- FR144220
- FR146881
- N-Acetyl-N-acetoxy-4-chlorobenzenesulfonamide
|
|---|
Enzyme (inhibitors) | | NOS | | nNOS | |
|---|
| iNOS |
- 1-Amino-2-hydroxyguanidine
- 2-Ethylaminoguanidine
- 2-Iminopiperidine
- 1400W
- AEITU
- Aminoguanidine (pimagedine)
- AMT
- AR-C 102222
- BYK-191023
- Canavanine
- Cindunistat (SD-6010)
- EITU
- IPTU
- MITU
- N5-(1-Iminoethyl)-L-ornithine (L-NIO)
- N6-(1-Iminoethyl)-L-lysine (L-NIL)
- Nω-Methyl-L-arginine (L-NMA)
- Ronopterin (VAS-203)
- TRIM
|
|---|
| eNOS | |
|---|
| Unsorted |
- Asymmetric dimethylarginine (ADMA)
- CKD-712
- Guanidinoethyldisulfide (GED)
- GW-273629
- Indospicine
- KD-7040
- Nitroarginine methyl ester (NAME)
- NCX-456
- NXN-462
- ONO-1714
- VAS-2381
|
|---|
|
|---|
| Arginase |
- ABH
- Nω-Hydroxy-L-arginine (NOHA)
- chlorogenic acid
- ginseng
- epicatechin
- ornithine
- norvaline
- lysine
- alpha aminoacids
|
|---|
| CAMK | |
|---|
|
|---|
| Others |
- Precursors: L-Arginine
- Nω-Hydroxy-L-arginine (NOHA)
- Cofactors: NADPH
- FAD
- FMN
- Heme
- BH4
- CaM
- O2
- Ca2+
- Indirect/downstream NO modulators: ACE inhibitors/AT-II receptor antagonists (e.g., captopril, losartan)
- ETB receptor antagonists (e.g., bosentan)
- L-Type calcium channel blockers (e.g., dihydropyridines: nifedipine)
- Nebivolol (beta blocker)
- PDE5 inhibitors (e.g., sildenafil)
- non-selective PDE inhibitors (e.g., caffeine)
- PDE9 inhibitors (e.g., paraxanthine)
- cGMP preferring PDE inhibitors (e.g., sildenafil, paraxanthine, tadalafil)
- Statins (e.g., simvastatin)
|
|---|
See also: Receptor/signaling modulators |